Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefit manager Express Scripts (ESRX +0.00%) has earned a respected four-star ranking.
With that in mind, let's take a closer look at Express Scripts and see what CAPS investors are saying about the stock right now.
Express Scripts facts
|
Headquarters (founded) |
St. Louis (1986) |
|
Market Cap |
$44.3 billion |
|
Industry |
Healthcare services |
|
Trailing-12-Month Revenue |
$78.9 billion |
|
Management |
Chairman/CEO George Paz CFO Jeffrey Hall |
|
Return on Equity (average, past 3 years) |
30.4% |
|
Cash / Debt |
$1.3 billion / $17.1 billion |
|
Competitors |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 94% of the 795 members who have rated Express Scripts believe the stock will outperform the S&P 500 going forward.
Just last month, one of those Fools, mwlove, tapped the stock as a particularly attractive investment candidate:
[T]he synergies of the Medco merger are paying off handsomely, and Express Scripts will benefit from health care reform. The market has over-reacted to management talk of "overly aggressive" forecasts. Other than that [faux pas], management has been exemplary and will take the company forward to a very bright future.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
